Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(17 sites)
United States
Clinical Trial Site, New Haven, Connecticut Clinical Trial Site, Detroit, Michigan Clinical Trial Site, New Brunswick, New Jersey Clinical Trial Site, New York, New York Clinical Trial Site, New York, New York Clinical Trial Site, Cleveland, Ohio Clinical Trial Site, Nashville, Tennessee Clinical Trial Site, Houston, Texas Canada
Clinical Trial Site, Toronto, Ontario Clinical Trial Site, Montreal, Quebec Denmark
Clinical Trial Site, Copenhagen Clinical Trial Site, Odense C Spain
Clinical Trial Site, El Palmar, Murcia Clinical Trial Site, Pamplona, Navarre Clinical Trial Site, Barcelona Clinical Trial Site, Madrid Clinical Trial Site, Salamanca